The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Open accessAbstract
The Yes-associated protein (YAP) is a transcription coactivator that plays a crucial role in organ size control by promoting cell proliferation and inhibiting apoptosis. The Hippo tumor suppressor pathway inhibits YAP through phosphorylation-induced cytoplasmic retention and degradation. Here we report a novel mechanism of YAP regulation by angiomotin (AMOT) family proteins via a direct interaction. Knockdown of AMOT family protein AMOTL2 in polarized Madin-Darby canine kidney (MDCK) cells leads to YAP activation, as indicated by decreased YAP tight junction localization, attenuated YAP phosphorylation, accumulation of nuclear YAP, and induction of YAP target gene expression. Transcriptional coactivator with PDZ-binding motif (TAZ), the YAP paralog, is also regulated by AMOT in a similar fashion. Furthermore, AMOTL2 knockdown results in loss of cell contact inhibition in a manner dependent on the functions of YAP and TAZ. Our results indicate a potential tumor-suppressing role of AMOT family proteins as components of the Hippo pathway, and demonstrate a novel mechanism of YAP and TAZ inhibition by AMOT-mediated tight junction localization. These observations provide a potential link between the Hippo pathway and cell contact inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Self-citationA coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
Self-citationYAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208445 · Cited by 584
Research works printed but not linked: 46
- 2006, Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases, Methods Enzymol, 407, 290, 10.1016/S0076-6879(05)07025-4 · DOI
- 10.1016/j.devcel.2009.01.010 · DOI · Paper page
- 2005, Multiple microalterations detected at high frequency in oral cancer, Cancer Res, 65, 7561, 10.1158/0008-5472.CAN-05-1513 · DOI
- 10.1016/S0378-1119(02)00928-9 · DOI
- 10.1111/j.1742-4658.2006.05427.x · DOI · Paper page
- 10.1158/0008-5472.CAN-07-2696 · DOI · Paper page
- 10.1016/j.cell.2007.07.019 · DOI · Paper page
- 10.1111/j.1742-4658.2006.05216.x · DOI
- 2008, Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells, Biochim Biophys Acta, 1783, 429, 10.1016/j.bbamcr.2007.11.018 · DOI
- 10.1101/gad.1824509 · DOI · Paper page
- 10.1016/j.cub.2010.01.055 · DOI · Paper page
- 10.1074/jbc.M709037200 · DOI · Paper page
- 10.1016/S0092-8674(03)00557-9 · DOI · Paper page
- 10.1016/j.bbrc.2006.03.244 · DOI
- 10.1016/j.ydbio.2009.10.042 · DOI
- 10.1038/ncb1853 · DOI · Paper page
- 10.1016/j.cell.2005.06.007 · DOI · Paper page
- 10.1101/gad.1134003 · DOI · Paper page
- 10.1242/dev.00168 · DOI · Paper page
- 10.1016/j.cell.2004.12.036 · DOI · Paper page
- 10.1073/pnas.1004279107 · DOI · Paper page
- 10.1200/JCO.2006.06.3701 · DOI
- 10.1016/j.cub.2006.08.057 · DOI · Paper page
- 10.1016/j.ydbio.2009.08.026 · DOI
- 10.1074/jbc.M804380200 · DOI · Paper page
- 10.1073/pnas.0605579103 · DOI · Paper page
- 10.1038/ncb1051 · DOI · Paper page
- 10.1016/j.cub.2010.03.019 · DOI · Paper page
- 10.1016/S0960-9822(03)00204-5 · DOI
- 10.1038/sj.onc.1208601 · DOI · Paper page
- 10.1073/pnas.0911409107 · DOI · Paper page
- 10.1016/j.humpath.2008.04.012 · DOI · Paper page
- 10.1016/S0092-8674(02)00824-3 · DOI · Paper page
- 10.1016/j.cell.2006.07.013 · DOI · Paper page
- 10.1083/jcb.152.6.1247 · DOI · Paper page
- 10.1038/ncb1050 · DOI · Paper page
- 10.1016/j.cell.2006.02.045 · DOI · Paper page
- 10.1016/S0092-8674(03)00549-X · DOI · Paper page
- 10.1002/cncr.24495 · DOI · Paper page
- 10.1016/j.cell.2006.05.030 · DOI · Paper page
- 10.1158/0008-5472.CAN-07-6205 · DOI · Paper page
- 10.1038/ncb1993 · DOI · Paper page
- 10.1158/0008-5472.SABCS-6033 · DOI
- 10.1101/gad.1664408 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-2997 · DOI
- 10.1101/gad.1909210 · DOI · Paper page
Cited by
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
Self-citationThe Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205
Self-citationYAP/TAZ upstream signals and downstream responses
Totaro, A., Panciera, T., & Piccolo, S. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0142-z · Cited by 1,086
Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
Hippo pathway effector Yap promotes cardiac regeneration
Xin, M., Kim, Y., Sutherland, L. B., Murakami, M., Qi, X., McAnally, J., Porrello, E. R., Mahmoud, A. I., Tan, W., Shelton, J. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313192110 · Cited by 895
Metadata
- Authors
- Zhao, B., Li, L., Lu, Q., Wang, L. H., Liu, C.-Y., Lei, Q., & Guan, K.-L.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-01-01
- Volume
- 25
- Issue
- 1
- Pages
- 51-63
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2143727653
- Cited by
- 665
- References
- 4
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. https://app.cochat.ai/papers/10.1101/gad.2000111
- The paper
- Zhao, B., Li, L., Lu, Q., Wang, L. H., Liu, C.-Y., Lei, Q., & Guan, K.-L. (2011). Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes & Development. https://doi.org/10.1101/gad.2000111
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.